Relief in the joints
Patients suffering from rheumatoid arthritis have shown a positive response to some experimental drugs. They experienced decrease in the pain and swelling in joints after taking these genetically engineered drugs. The drugs inhibit the action of a substance called tumour necrosis factor (TNF) that is responsible for the severe pain and swelling of rheumatoid arthritis. Michael Winblatt of Brigham and Woman's Hospital, Boston, USA, studied 234 patients with active, long-standing rheumatoid arthritis. Some patients who were given 25 mg injections of Enbrel experienced 71 per cent relief in painful joints. Enbrel has been developed by Immunex Corp, Seatle, USA. Another drug, Avakine, developed by Centocor Inc, Malvern, Pennsylvania, USA, has shown similar results.
Related Content
- Compliance report filed by Singareni Collieries, Khammam district, Telangana, 06/10/2021
- Order of the Supreme Court regarding protection of forest officers and staff, 08/01/2021
- Order of the National Green Tribunal regarding untreated effluents from industries affecting water quality, Zahirabad, Sangareddy District, Telangana, 08/08/2019
- Order of the National Green Tribunal regarding closure of TSDF established by M/s Ramky Enviro Engineers, Karnataka, 22/04/2019
- Order of the National Green Tribunal regarding leather industries causing pollution to river Ganga, Jajmau Kanpur, Uttar Pradesh, 14/01/2016
- Nepal State of Environment Report: The Monthly Overview, November, 2014